Skip to main content
OpenTrials

Clinical trial condition

Indolent Non-hodgkin Lymphoma

Explore clinical trials studying Indolent Non-hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.

24 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Indolent Non-hodgkin Lymphoma trial results

Active, not recruiting

Parsaclisib Plus the Standard Drug Therapy in Patients With Newly Diagnosed, High Risk Diffuse Large B-cell Lymphoma

NCT04323956

Conditions
Ann Arbor Stage II Diffuse Large B-Cell Lymphoma, Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage II Marginal Zone Lymphoma, +22 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
View Trial Details
Completed

Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant

NCT01231412

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, +58 more
Locations
  • University of Colorado Denver, Colorado, United States
  • Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
View Trial Details
Completed

A Study of Axicabtagene Ciloleucel in Participants With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma

NCT03105336

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Georgetown Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States
View all 19 locations
View Trial Details
Completed

A Phase 2 Study Comparing 2 Intermittent Dosing Schedules of Duvelisib in Participants With Indolent Non-Hodgkin Lymphoma

NCT04038359

Conditions
Indolent Non-hodgkin Lymphoma
Locations
  • Florida Cancer Specialists - Fort Myers Fort Myers, Florida, United States
  • Florida Cancer Specialists & Research Institute - Lecanto Lecanto, Florida, United States
  • Mid-Florida Cancer Centers Orange City, Florida, United States
  • Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States
View all 28 locations
View Trial Details
Completed

NKTR-255 in Relapsed/Refractory Multiple Myeloma & Non-Hodgkin Lymphoma

NCT04136756

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +21 more
Locations
  • Western Regional Medical Center - CTCA Goodyear, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
View all 13 locations
View Trial Details

Related conditions